- Home
- FENC vs PESI Comparison
FENC vs PESI Comparison
Compare FENC & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- PESI
- Stock Information
- Founded
- FENC 1996
- PESI 1990
- Country
- FENC United States
- PESI United States
- Employees
- FENC N/A
- PESI N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- PESI Environmental Services
- Sector
- FENC Health Care
- PESI Industrials
- Exchange
- FENC Nasdaq
- PESI Nasdaq
- Market Cap
- FENC 225.4M
- PESI 205.4M
- IPO Year
- FENC 2001
- PESI 1992
- Fundamental
- Price
- FENC $8.67
- PESI $8.75
- Analyst Decision
- FENC Strong Buy
- PESI
- Analyst Count
- FENC 2
- PESI 0
- Target Price
- FENC $13.50
- PESI N/A
- AVG Volume (30 Days)
- FENC 54.7K
- PESI 271.9K
- Earning Date
- FENC 11-06-2025
- PESI 11-12-2025
- Dividend Yield
- FENC N/A
- PESI N/A
- EPS Growth
- FENC N/A
- PESI N/A
- EPS
- FENC N/A
- PESI N/A
- Revenue
- FENC $33,302,000.00
- PESI $60,019,000.00
- Revenue This Year
- FENC $0.96
- PESI $8.35
- Revenue Next Year
- FENC $51.71
- PESI $82.81
- P/E Ratio
- FENC N/A
- PESI N/A
- Revenue Growth
- FENC N/A
- PESI N/A
- 52 Week Low
- FENC $3.96
- PESI $6.25
- 52 Week High
- FENC $9.42
- PESI $16.25
- Technical
- Relative Strength Index (RSI)
- FENC 48.27
- PESI 31.86
- Support Level
- FENC $8.96
- PESI $8.02
- Resistance Level
- FENC $9.13
- PESI $12.32
- Average True Range (ATR)
- FENC 0.28
- PESI 0.82
- MACD
- FENC -0.02
- PESI -0.38
- Stochastic Oscillator
- FENC 17.88
- PESI 16.98
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.